ArticleExperimental and therapeutic medicine2020

Inhibition of miR-96 enhances the sensitivity of colorectal cancer cells to oxaliplatin by targeting TPM1.

Tingrui Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.